KRT18 and neoplasm: Cytokeratins 8 and 18 (CK8 and CK18) are co-expressed in healthy mammary glands, and while their expression in tumor tissue negatively correlates with rates of recurrence, ER status, and tumor grade, CK8/18 are expressed by breast cancer CTCs [21].